The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance
Open accessAbstract
Breast cancer evolution and tumor progression are governed by the complex interactions between steroid receptor [estrogen receptor (ER) and progesterone receptor] and growth factor receptor signaling. In recent years, the field of cancer therapy has witnessed the emergence of multiple strategies targeting these specific cancer pathways and key molecules (ER and growth factor receptors) to arrest tumor growth and achieve tumor eradication; treatment success, however, has varied and both de novo (up front) and acquired resistance have proven a challenge. Recent studies of ER biology have revealed new insights into ER action in breast cancer and have highlighted the role of an intimate crosstalk between the ER and HER family signaling pathways as a fundamental contributor to the development of resistance to endocrine therapies against the ER pathway. The aim of this review article is to summarize the current knowledge on mechanisms of resistance of breast cancer cells to endocrine therapies due to the crosstalk between the ER and the HER growth factor receptor signaling pathways and to explore new available therapeutic strategies that could prolong duration of response and circumvent endocrine resistant tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wong, C.-W., McNally, C., Nickbarg, E., Komm, B. S., & Cheskis, B. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192569699 · Cited by 324
RetractedEstradiol Rapidly Activates Akt via the ErbB2 Signaling Pathway
Stoica, G. E., Franke, T. F., Wellstein, A., Czubayko, F., List, H.-J., Reiter, R., Morgan, E., Martin, M. B., & Stoica, A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0330 · Cited by 118
RetractedNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Shiau, A. K., Barstad, D., Loria, P. M., Cheng, L., Kushner, P. J., Agard, D. A., & Greene, G. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81717-1 · Cited by 2,729
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Hörlein, A. J., Näär, A. M., Heinzel, T., Torchia, J., Gloss, B., Kurokawa, R., Ryan, A., Kamei, Y., Söderström, M., Glass, C. K., et al. (1995) · Nature · doi:10.1038/377397a0 · Cited by 2,034
Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Goss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa032312 · Cited by 1,795
A transcriptional co-repressor that interacts with nuclear hormone receptors
Chen, J. D., & Evans, R. M. (1995) · Nature · doi:10.1038/377454a0 · Cited by 1,763
Shou, J., Massarweh, S., Osborne, C. K., Wakeling, A. E., Ali, S., Weiss, H., & Schiff, R. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh166 · Cited by 1,153
Self-citationGoss, P. E., Ingle, J. N., Martino, S., Robert, N. J., Muss, H. B., Piccart, M. J., Castiglione, M., Tu, D., Shepherd, L. E., Pritchard, K. I., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji250 · Cited by 1,118
Estrogen receptor interaction with estrogen response elements
Klinge, C. M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.14.2905 · Cited by 1,081
Hall, J. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7179 · Cited by 1,075
Ellis, M. J., Coop, A., Singh, B., Mauriac, L., Llombert-Cussac, A., Jänicke, F., Miller, W. R., Evans, D. B., Dugan, M., Brady, C., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.18.3808 · Cited by 1,060
Razandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0239 · Cited by 1,040
Bunone, G., Briand, P. A., Miksicek, R. J., & Picard, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00571.x · Cited by 986
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α
Campbell, R. A., Bhat-Nakshatri, P., Patel, N. M., Constantinidou, D., Ali, S., & Nakshatri, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010840200 · Cited by 968
Howell, A. (1998) · PubMed · Cited by 901
Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S., & Coombes, R. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc721 · Cited by 883
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Estrogen receptor pathways to AP-1
Kushner, P. J., Agard, D. A., Greene, G. L., Scanlan, T. S., Shiau, A. K., Uht, R. M., & Webb, P. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00108-4 · Cited by 870
Lakhani, S. R., van de Vijver, M. J., Jacquemier, J., Anderson, T. J., Osin, P. P., McGuffog, L., & Easton, D. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.023 · Cited by 823
Osborne, C. K., Bardou, V., Hopp, T. A., Chamness, G. C., Hilsenbeck, S. G., Fuqua, S. A. W., Wong, J., Allred, D. C., Clark, G. M., & Schiff, R. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.353 · Cited by 786
Self-citationSmith, I. E., Dowsett, M., Ebbs, S. R., Dixon, J. M., Skene, A., Blohmer, J.-U., Ashley, S. E., Francis, S., Boeddinghaus, I., & Walsh, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.005 · Cited by 774
Bardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
Self-citationEstrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu
Benz, C. C., Scott, G. K., Sarup, J. C., Johnson, R. M., Tripathy, D., Coronado, E., Shepard, H. M., & Osborne, C. K. (1992) · Breast Cancer Research and Treatment · doi:10.1007/bf01961241 · Cited by 750
Self-citationRusnak, D. W., Lackey, K. E., Affleck, K., Wood, E. R., Alligood, K. J., Rhodes, N., Keith, B. R., Murray, D. M., Knight, W. B., Mullin, R. J., et al. (2001) · PubMed · Cited by 728
The value of estrogen and progesterone receptors in the treatment of breast cancer
Osborne, C. K., Yochmowitz, M. G., Knight, W. A., & McGuire, W. L. (1980) · Cancer · doi:10.1002/1097-0142(19801215)46:12+<2884::aid-cncr2820461429>3.0.co;2-u · Cited by 720
Self-citationDowsett, M., Smith, I. E., Ebbs, S. R., Dixon, J. M., Skene, A., A'Hern, R., Salter, J., Detre, S., Hills, M., & Walsh, G. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk020 · Cited by 665
Xia, W., Mullin, R. J., Keith, B. R., Liu, L.-H., Ma, H., Rusnak, D. W., Owens, G., Alligood, K. J., & Spector, N. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205794 · Cited by 664
Smith, C. S., Nawaz, Z., & O’Malley, B. W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.657 · Cited by 662
Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.
Lavinsky, R. M., Jepsen, K., Heinzel, T., Torchia, J., Mullen, T.-M., Schiff, R., Del-Rio, A. L., Ricote, M., Ngo, S., Gemsch, J., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2920 · Cited by 660
Self-citationBurris, H. A., Hurwitz, H. I., Dees, E. C., Dowlati, A., Blackwell, K. L., O'Neil, B., Marcom, P. K., Ellis, M. J., Overmoyer, B., Jones, S. F., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.16.584 · Cited by 619
Pietras, R. J., Arboleda, J., Dm, R., Wongvipat, N., Pegram, M. D., Ramos, L., Cm, G., Mg, P., Sliwkowski, M. X., & Dj, S. (1995) · PubMed · Cited by 603
Konecny, G., Pauletti, G., Pegram, M., Untch, M., Dandekar, S., Aguilar, Z., Wilson, C., Rong, H.-M., Bauerfeind, I., Felber, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.142 · Cited by 588
Nature of Functional Estrogen Receptors at the Plasma Membrane
Pedram, A., Razandi, M., & Levin, E. R. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0525 · Cited by 522
Knowlden, J. M., Hutcheson, I. R., Jones, H. E., Madden, T., Gee, J. M. W., Harper, M. E., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2002-220620 · Cited by 521
The SRC family of nuclear receptor coactivators
Leo, C., & Chen, J. D. (2000) · Gene · doi:10.1016/s0378-1119(00)00024-x · Cited by 520
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
Cui, X., Schiff, R., Arpino, G., Osborne, C. K., & Lee, A. V. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.004 · Cited by 514
Self-citationHER-2 gene amplification can be acquired as breast cancer progresses
Meng, S., Tripathy, D., Shete, S., Ashfaq, R., Haley, B., Perkins, S., Beitsch, P., Khan, A., Euhus, D., Osborne, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402993101 · Cited by 508
Self-citationGutierrez, M. C., Detre, S., Johnston, S., Mohsin, S. K., Shou, J., Allred, D. C., Schiff, R., Osborne, C. K., & Dowsett, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.172 · Cited by 489
Self-citationArpino, G., Weiss, H., Lee, A. V., Schiff, R., De Placido, S., Osborne, C. K., & Elledge, R. M. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji249 · Cited by 484
Self-citationProximal Events in Signaling by Plasma Membrane Estrogen Receptors
Razandi, M., Pedram, A., Park, S. T., & Levin, E. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205692200 · Cited by 473
Li, L., Haynes, M. P., & Bender, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831079100 · Cited by 465
Schiff, R., Massarweh, S. A., Shou, J., Bharwani, L., Mohsin, S. K., & Osborne, C. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-031212 · Cited by 462
Self-citationLange, C. A., Shen, T., & Horwitz, K. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1032 · Cited by 450
A Conserved Mechanism for Steroid Receptor Translocation to the Plasma Membrane
Pedram, A., Razandi, M., Sainson, R. C. A., Kim, J. K., Hughes, C. C., & Levin, E. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611877200 · Cited by 446
AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor
Font de Mora, J., & Brown, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.5041-5047.2000 · Cited by 432
Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions
Safe, S. (2001) · Vitamins & Hormones · doi:10.1016/s0083-6729(01)62006-5 · Cited by 418
Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer
Baselga, J., Albanell, J., Ruiz, A., Lluch, A., Gascón, P., Guillém, V., González, S., Sauleda, S., Marimón, I., Tabernero, J. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.326 · Cited by 411
Estrogen-Like Activity of Metals in Mcf-7 Breast Cancer Cells
Martin, M. B., Reiter, R., Pham, T., Avellanet, Y. R., Camara, J., Lahm, M., Pentecost, E., Pratap, K., Gilmore, B. A., Divekar, S., et al. (2003) · Endocrinology · doi:10.1210/en.2002-221054 · Cited by 409
Razandi, M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.100 · Cited by 402
deGraffenried, L. A., Friedrichs, W. E., Russell, D. H., Donzis, E. J., Middleton, A. K., Silva, J. M., Roth, R. A., & Hidalgo, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0035 · Cited by 387
Wang, Z., Zhang, X., Shen, P., Loggie, B. W., Chang, Y., & Deuel, T. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603339103 · Cited by 380
TRANSCRIPTION ACTIVATION BY ESTROGEN AND PROGESTERONE RECEPTORS
Gronemeyer, H. (1991) · Annual Review of Genetics · doi:10.1146/annurev.ge.25.120191.000513 · Cited by 378
Xia, W., Bacus, S., Hegde, P., Husain, I., Strum, J., Liu, L., Paulazzo, G., Lyass, L., Trusk, P., Hill, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602468103 · Cited by 374
Kurokawa, H., Lenferink, A. E. G., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., & Arteaga, C. L. (2000) · PubMed · Cited by 363
Spector, N. L., Xia, W., Burris, H., Hurwitz, H., Dees, E. C., Dowlati, A., O'Neil, B., Overmoyer, B., Marcom, P. K., Blackwell, K. L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.12.157 · Cited by 362
Estrogen-Receptor Biology: Continuing Progress and Therapeutic Implications
Osborne, C. K., & Schiff, R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.036 · Cited by 351
Self-citationSong, R. X., Barnes, C. J., Zhang, Z., Bao, Y., Kumar, R., & Santen, R. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308334100 · Cited by 349
Ligand-independent activation of steroid hormone receptors
Weigel, N. L., & Zhang, Y. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050241 · Cited by 345
De Laurentiis, M., Arpino, G., Massarelli, E., Ruggiero, A., Carlomagno, C., Ciardiello, F., Tortora, G., D'Agostino, D., Caputo, F., Cancello, G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2569 · Cited by 340
Self-citationPrevention of Brca1 -Mediated Mammary Tumorigenesis in Mice by a Progesterone Antagonist
Poole, A. J., Li, Y., Kim, Y., Lin, S.-C. J., Lee, W.-H., & Lee, E. Y.-H. P. (2006) · Science · doi:10.1126/science.1130471 · Cited by 332
Plasma Membrane Estrogen Receptors Exist and Functions as Dimers
Razandi, M., Pedram, A., Merchenthaler, I., Greene, G. L., & Levin, E. R. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0115 · Cited by 330
Bidirectional Signaling between the Estrogen Receptor and the Epidermal Growth Factor Receptor
Levin, E. R. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0368 · Cited by 329
Elledge, R. M., Green, S., Pugh, R., Allred, D. C., Clark, G. M., Hill, J., Ravdin, P., Martino, S., & Osborne, C. K. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2<111::aid-ijc2>3.0.co;2-w · Cited by 325
Self-citationRazandi, M., Alton, G., Pedram, A., Ghonshani, S., Webb, P., & Levin, E. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1633-1646.2003 · Cited by 323
Schiff, R., Massarweh, S. A., Shou, J., & Osborne, C. K. (2003) · PubMed · Cited by 304
Self-citationWu, R.-C., Qin, J., Yi, P., Wong, J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.019 · Cited by 296
Integration of the Non-genomic and Genomic Actions of Estrogen
Pedram, A., Razandi, M., Aitkenhead, M., Hughes, C. C. W., & Levin, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m210106200 · Cited by 293
Dowsett, M., Ebbs, S. R., Dixon, J. M., Skene, A., Griffith, C., Boeddinghaus, I., Salter, J., Detre, S., Hills, M., Ashley, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.559 · Cited by 288
Plasma Membrane Estrogen Receptors Are Coupled to Endothelial Nitric-oxide Synthase through Gαi
Wyckoff, M. H., Chambliss, K. L., Mineo, C., Yuhanna, I. S., Mendelsohn, M. E., Mumby, S. M., & Shaul, P. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100312200 · Cited by 282
Lu, Q., Pallas, D. C., Surks, H. K., Baur, W. E., Mendelsohn, M. E., & Karas, R. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407492101 · Cited by 266
Dowsett, M., Cuzick, J., Wale, C., Howell, T., Houghton, J., & Baum, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.4829 · Cited by 260
McClelland, R. A., Barrow, D., Madden, T., Dutkowski, C. M., Pamment, J., Knowlden, J. M., Gee, J. M. W., & Nicholson, R. I. (2001) · Endocrinology · doi:10.1210/en.142.7.2776 · Cited by 258
Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator Activity by IκB Kinase
Wu, R.-C., Qin, J., Hashimoto, Y., Wong, J., Xu, J., Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3549-3561.2002 · Cited by 257
Ray, P., Ghosh, S. K., Zhang, D.-H., & Ray, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00487-0 · Cited by 256
Arpino, G., Green, S. J., Allred, D. C., Lew, D., Martino, S., Osborne, C. K., & Elledge, R. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0110 · Cited by 255
Self-citationChu, I., Blackwell, K., Chen, S., & Slingerland, J. (2005) · Cancer Research · doi:10.1158/0008-5472.18.65.1 · Cited by 251
A naturally occurring MTA1 variant sequesters oestrogen receptor-α in the cytoplasm
Kumar, R., Wang, R.-A., Mazumdar, A., Talukder, A. H., Mandal, M., Yang, Z., Bagheri-Yarmand, R., Sahin, A., Hortobagyi, G., Adam, L., et al. (2002) · Nature · doi:10.1038/nature00889 · Cited by 242
Cui, X., Zhang, P., Deng, W., Oesterreich, S., Lu, Y., Mills, G. B., & Lee, A. V. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0318 · Cited by 233
Martin, M. B., Franke, T. F., Stoica, G. E., Chambon, P., Katzenellenbogen, B. S., Stoica, B. A., McLemore, M. S., Olivo, S. E., & Stoica, A. (2000) · Endocrinology · doi:10.1210/endo.141.12.7836 · Cited by 231
Plasma Membrane Estrogen Receptors Signal to Antiapoptosis in Breast Cancer
Razandi, M., Pedram, A., & Levin, E. R. (2000) · Molecular Endocrinology · doi:10.1210/me.14.9.1434 · Cited by 228
Shen, T., Horwitz, K. B., & Lange, C. A. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6122-6131.2001 · Cited by 204
Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen, B. S., Montano, M. M., Ediger, T. R., Sun, J., Ekena, K., Lazennec, G., Martini, P. G. V., McInerney, E. M., Delage-Mourroux, R., Weis, K. E., et al. (2000) · PubMed · Cited by 202
Smith, I. E., Walsh, G., Skene, A., Llombart, A., Mayordomo, J. I., Detre, S., Salter, J., Clark, E., Magill, P., & Dowsett, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.6578 · Cited by 201
Convergence of Progesterone and Epidermal Growth Factor Signaling in Breast Cancer
Lange, C. A., Richer, J. K., Shen, T., & Horwitz, K. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31308 · Cited by 200
Diversity in the mechanisms of gene regulation by estrogen receptors
Sanchez, R., Nguyen, D., Rocha, W., White, J. H., & Mader, S. (2002) · BioEssays · doi:10.1002/bies.10066 · Cited by 199
Low Levels of Estrogen Receptor β Protein Predict Resistance to Tamoxifen Therapy in Breast Cancer
Hopp, T. A., Weiss, H. L., Parra, I. S., Cui, Y., Osborne, C. K., & Fuqua, S. A. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1114 · Cited by 197
Self-citationEstrogen receptor: current understanding of its activation and modulation.
Osborne, C. K., Schiff, R., Fuqua, S. A. W., & Shou, J. (2001) · PubMed · Cited by 194
Self-citationPolychronis, A., Sinnett, H. D., Hadjiminas, D., Singhal, H., Mansi, J. L., Shivapatham, D., Shousha, S., Jiang, J., Peston, D., Barrett, N., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70176-5 · Cited by 194
Targeting epidermal growth factor receptor—are we missing the mark?
Dancey, J. E., & Freidlin, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13810-x · Cited by 192
Knowlden, J. M., Hutcheson, I. R., Barrow, D., Gee, J. M. W., & Nicholson, R. I. (2005) · Endocrinology · doi:10.1210/en.2005-0247 · Cited by 188
Arpino, G., Gutierrez, C., Weiss, H., Rimawi, M., Massarweh, S., Bharwani, L., De Placido, S., Osborne, C. K., & Schiff, R. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk151 · Cited by 188
Self-citationHong, S.-H., & Privalsky, M. L. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.17.6612-6625.2000 · Cited by 186
First-line, single-agent Herceptin® (trastuzumab) in metastatic breast cancer
Vogel, C., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00405-6 · Cited by 183
Lange, C. A., Richer, J. K., & Horwitz, K. B. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0290 · Cited by 181
Berry, D. A., Muss, H. B., Thor, A. D., Dressler, L., Liu, E. T., Broadwater, G., Budman, D. R., Henderson, I. C., Barcos, M., Hayes, D., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.20.3471 · Cited by 180
Nicholson, R. I., McClelland, R. A., Finlay, P., Eaton, C. L., Gullick, W. J., Dixon, A. R., Robertson, J. F. R., Blamey, R. W., & Ellis, I. O. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80215-1 · Cited by 178
Characterization of the Interactions of Estrogen Receptor and MNAR in the Activation of cSrc
Barletta, F., Wong, C.-W., McNally, C., Komm, B. S., Katzenellenbogen, B., & Cheskis, B. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0335 · Cited by 176
Ellis, M. J., Tao, Y., Young, O., White, S., Proia, A. D., Murray, J., Renshaw, L., Faratian, D., Thomas, J., Dowsett, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3034 · Cited by 173
Gee, J. M. W., Harper, M. E., Hutcheson, I. R., Madden, T. A., Barrow, D., Knowlden, J. M., McClelland, R. A., Jordan, N., Wakeling, A. E., & Nicholson, R. I. (2003) · Endocrinology · doi:10.1210/en.2003-0705 · Cited by 170
Márquez, D. C., & Pietras, R. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204729 · Cited by 170
Estrogen receptors outside the nucleus in breast cancer
Levin, E. R., & Pietras, R. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9618-4 · Cited by 168
Archer, S., Eliopoulos, A., Spandidos, D., Barnes, D., Ellis, I., Blamey, R., Nicholson, R., & Robertson, J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.497 · Cited by 159
Marcom, P. K., Isaacs, C. J., Harris, L. N., Wong, Z. W., Kommareddy, A., Novielli, N., Mann, G., Tao, Y., & Ellis, M. J. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9307-8 · Cited by 154
Lopez, G. N., Turck, C. W., Schaufele, F., Stallcup, M. R., & Kushner, P. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010718200 · Cited by 154
Truncated Estrogen Receptor α 46-kDa Isoform in Human Endothelial Cells
Figtree, G. A., McDonald, D., Watkins, H. C., & Channon, K. M. (2003) · Circulation · doi:10.1161/01.cir.0000043805.11780.f5 · Cited by 149
Lee, A. V., Cui, X., & Oesterreich, S. (2001) · PubMed · Cited by 146
Chung, Y., Sheu, M., Yang, S., Lin, C., & Yen, S. (2001) · International Journal of Cancer · doi:10.1002/ijc.1614 · Cited by 142
Tovey, S., Dunne, B., Witton, C. J., Forsyth, A., Cooke, T. G., & Bartlett, J. M. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0196 · Cited by 141
Pierson-Mullany, L. K., & Lange, C. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10542-10557.2004 · Cited by 140
Johnston, S. R. D., Head, J. E., Pancholi, S., DETRE, S. I., Martin, L., Smith, I. E., & Dowsett, M. (2003) · PubMed · Cited by 138
Mauriac, L., Keshaviah, A. P., Debled, M., Mouridsen, H. T., Forbes, J., Thurlimann, B. J. K., Paridaens, R., Monnier, A., Láng, I., Wardley, A. M., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm001 · Cited by 136
Increased Constitutive Activity of PKB/Akt in Tamoxifen Resistant Breast Cancer MCF-7 Cells
Jordan, N., Gee, J. M. W., Barrow, D., Wakeling, A. E., & Nicholson, R. I. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000041623.21338.47 · Cited by 127
Zwart, W. T., Griekspoor, A., Berno, V., Lakeman, K. A. M., Jalink, K., Mancini, M. A., Neefjes, J., & Michalides, R. J. A. M. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601791 · Cited by 119
Nonendocrine Pathways and Endocrine Resistance
Nicholson, R. I., Hutcheson, I. R., Knowlden, J. M., Jones, H., Harper, M. E., Jordan, N., Hiscox, S., Barrow, D., & Gee, J. M. W. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-031206 · Cited by 117
Aromatase inhibitors in breast cancer.
Lønning, P. E. (2004) · Endocrine Related Cancer · doi:10.1677/erc.0.0110179 · Cited by 115
Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer
Márquez, D. C., Chen, H., Curran, E. M., Welshons, W. V., & Pietras, R. J. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.020 · Cited by 112
Razandi, M., Pedram, A., Rosen, E. M., & Levin, E. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5900-5913.2004 · Cited by 108
Kirkegaard, T., McGlynn, L. M., Campbell, F., Müller, S., Tovey, S., Dunne, B., Nielsen, K. V., Cooke, T. G., & Bartlett, J. M. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1933 · Cited by 104
Dowsett, M., Bundred, N. J., DeCensi, A., Sainsbury, R., Lu, Y., Hills, M. J., Cohen, F. J., Veronesi, P., O'Brien, M. E. R., Scott, T., et al. (2001) · PubMed · Cited by 104
Jeng, M., Yue, W., Eischeid, A. C., Wang, J., & Santen, R. J. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006406030612 · Cited by 99
Lipton, A., Leitzel, K., Ali, S. M., et al. (2005) · Cancer · doi:10.1002/cncr.21202 · Cited by 98
Blackwell, K., Kaplan, E., Franco, S. X., Marcom, P. K., Maleski, J. E., Sorensen, M. J., & Berger, M. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.90140.3006 · Cited by 96
Daniel, A. R., Qiu, M., Faivre, E. J., Ostrander, J. H., Skildum, A. J., & Lange, C. A. (2006) · Steroids · doi:10.1016/j.steroids.2006.11.009 · Cited by 87
Overcoming Endocrine Therapy Resistance by Signal Transduction Inhibition
Ellis, M. J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_3-20 · Cited by 84
Klinge, C. M., Jernigan, S. C., Smith, S. L., Tyulmenkov, V. V., & Kulakosky, P. C. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00382-3 · Cited by 82
Steroid Receptors and Their Role in the Biology and Control of Breast Cancer Growth
Cordera, F., & Jordan, V. C. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.08.020 · Cited by 80
Membrane receptors for steroid hormones: Signal transduction and physiological significance
Nemere, I., Pietras, R. J., & Blackmore, P. F. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10409 · Cited by 76
Johnston, S. R. D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.889s.11.2 · Cited by 75
Balasenthil, S., Barnes, C. J., Rayala, S. K., & Kumar, R. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.04.071 · Cited by 75
Bamberger, A., Milde‐Langosch, K., Schulte, H. M., & Löning, T. (2000) · Hormone Research in Paediatrics · doi:10.1159/000063434 · Cited by 75
Epidermal Growth Factor Receptor and Tyrosine Phosphorylation of Estrogen Receptor
Márquez, D. C., Lee, J. A., Lin, T. K., & Pietras, R. J. (2001) · Endocrine · doi:10.1385/endo:16:2:073 · Cited by 75
Synergistic Interactions between Tamoxifen and Trastuzumab (Herceptin)
Argiris, A. E., Wang, C.-X., Whalen, S. G., & DiGiovanna, M. P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1060-02 · Cited by 73
Nuclear receptor conformation, coregulators, and tamoxifen-resistant breast cancer.
Graham, J., Bain, D. L., Richer, J., Jackson, T., Tung, L., & Horwitz, K. (2000) · Steroids · doi:10.1016/s0039-128x(00)00116-1 · Cited by 68
Integration of progesterone receptor action with rapid signaling events in breast cancer models
Lange, C. A. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.09.019 · Cited by 67
Gradishar, W. J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-4-378 · Cited by 67
Natriuretic Peptides Inhibit G Protein Activation
Pedram, A., Razandi, M., Kehrl, J. H., & Levin, E. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7365 · Cited by 66
Chambliss, K. L., Simon, L., Yuhanna, I. S., Mineo, C., & Shaul, P. W. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0008 · Cited by 65
Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women
Balleine, R. L., Earl, M. J., Greenberg, M. L., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690249 · Cited by 64
Aupperlee, M. D., Kariagina, A., Osuch, J. R., & Haslam, S. Z. (2006) · Breast Disease · doi:10.3233/bd-2006-24104 · Cited by 47
Hu, J., & Mokbel, K. (2001) · European Journal of Surgical Oncology · doi:10.1053/ejso.2000.1078 · Cited by 27
Aromatase inhibitors: Future directions
Osborne, C. K., & Schiff, R. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.04.021 · Cited by 26
Self-citationXenograft models for aromatase inhibitor studies
Brodie, A. M., Sabnis, G. J., & Macedo, L. F. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.010 · Cited by 22
Cited by
Goldhirsch, A., Ingle, J. N., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp322 · Cited by 1,374
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
Johnston, S., Pippen, J., Pivot, X., Lichinitser, M., Sadeghi, S., Dieras, V., Gomez, H. L., Romieu, G., Manikhas, A., Kennedy, M. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3734 · Cited by 1,025
Saura, C., Oliveira, M., Feng, Y.-H., Dai, M.-S., Chen, S.-W., Hurvitz, S. A., Kim, S.-B., Moy, B., Delaloge, S., Gradishar, W., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00147 · Cited by 604
Martin, M., Holmes, F. A., Ejlertsen, B., Delaloge, S., Moy, B., Iwata, H., von Minckwitz, G., Chia, S. K. L., Mansi, J., Barrios, C. H., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30717-9 · Cited by 585
Self-citation
Metadata
- Authors
- Arpino, G., Wiechmann, L., Osborne, C. K., & Schiff, R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-01-23
- Volume
- 29
- Issue
- 2
- Pages
- 217-233
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2022102157
- Cited by
- 549
- References
- 152
- FWCI
- 25.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.